References
- Jo JK, Song HK, Heo Y, et al. Risk analysis of metformin use in prostate cancer: a national population-based study. Aging Male. 2023;26(1):2156497. doi:10.1080/13685538.2022.2156497.
- McCarthy CP, Shrestha S, Ibrahim N, et al. Performance of a clinical/proteomic panel to predict obstructive peripheral artery disease in patients with and without diabetes mellitus. Open Heart. 2019;6(1):e000955. doi:10.1136/openhrt-2018-000955.